Neuroplasticity and cellular resilience in mood disorders.
about
A systematic, updated review on the antidepressant agomelatine focusing on its melatonergic modulationVGF, a new player in antidepressant action?Astrocyte pathology in major depressive disorder: insights from human postmortem brain tissueBipolar spectrum: a review of the concept and a vision for the futureNeurobiology of mood, anxiety, and emotions as revealed by studies of a unique antidepressant: tianeptineDepression, antidepressants, and neurogenesis: a critical reappraisal.Glycogen synthase kinase-3 in the etiology and treatment of mood disorders.A systematic review of existing data on long-term lithium therapy: neuroprotective or neurotoxic?Chronic NMDA administration to rats increases brain pro-apoptotic factors while decreasing anti-Apoptotic factors and causes cell death.Effects of repeated citalopram treatments on chronic mild stress-induced growth associated protein-43 mRNA expression in rat hippocampus.Hippocampus atrophy and the longitudinal course of late-life depressionPhysical Activity Modulates Common Neuroplasticity Substrates in Major Depressive and Bipolar Disorder.Cingulate metabolites during pain and morphine treatment as assessed by magnetic resonance spectroscopy.Effects of the brain-derived neurotrophic growth factor val66met variation on hippocampus morphology in bipolar disorder.BDNF gene polymorphism (Val66Met) predicts amygdala and anterior hippocampus responses to emotional faces in anxious and depressed adolescents.Stable isotope-resolved metabolomic analysis of lithium effects on glial-neuronal metabolism and interactionsLong-term adaptive changes induced by serotonergic antidepressant drugs.Pharmacogenomics of mood stabilizers in the treatment of bipolar disorder.Effects of erythropoietin on depressive symptoms and neurocognitive deficits in depression and bipolar disorder.Diagnosis and management of depression in primary care: a clinical update and review.Antidepressant chronotherapeutics for bipolar depression.Australian and New Zealand clinical practice guidelines for the treatment of bipolar disorder.Proteomic analysis of lymphoblastoid cells derived from monozygotic twins discordant for bipolar disorder: a preliminary study.PKC, MAP kinases and the bcl-2 family of proteins as long-term targets for mood stabilizers.Endophenotypes in bipolar disorder.Cell pathology in bipolar disorder.Epigenetic and inflammatory marker profiles associated with depression in a community-based epidemiologic sample.Modulation of synaptic plasticity by stress and antidepressants.Spatial inhibition and the visual cortex: a magnetic resonance spectroscopy imaging studyCircuits and systems in stress. II. Applications to neurobiology and treatment in posttraumatic stress disorder.The Wnt signaling pathway in bipolar disorder.Association between brain-derived neurotrophic factor genetic polymorphism Val66Met and susceptibility to bipolar disorder: a meta-analysis.Creatine supplementation associated or not with strength training upon emotional and cognitive measures in older women: a randomized double-blind studyEmerging therapeutic targets in bipolar mood disorder.Stress hormone-related psychopathology: pathophysiological and treatment implications.Affective disorders, antidepressant drugs and brain metabolism.Prophylaxis latency and outcome in bipolar disorders.Enhancing synaptic plasticity and cellular resilience to develop novel, improved treatments for mood disorders.Loss of Glial Cells of the Hippocampus in a Rat Model of Post-traumatic Stress Disorder.The association of genetic variation in CACNA1C with structure and function of a frontotemporal system.
P2860
Q22305782-BCEED881-9460-4E78-9C42-C4FAD9547AE1Q24653586-318EF836-F9E1-4F73-A59F-6F06B810D9B7Q26827833-33035E8C-AF0E-42DC-ABFF-311B19AE0EDBQ27010258-E9E4058A-330C-423E-BB98-F7613D77F320Q28238686-852ACD61-245A-4412-8D24-A5CD2C536176Q30460361-35F2AC74-013B-41E2-B3CD-9D35C3B550B3Q30474415-ACBB38FA-57AF-4EAE-930E-AF27867E57EAQ33284843-D4CD7A0C-4B4C-41BA-AC5C-483E3A5AB0B0Q33507174-B395EB5A-8D5D-4EB1-914E-587EE74E3F0EQ33633970-B2A3499C-33E2-40E5-A32D-A89EF1F70329Q33651164-DB99075C-D78E-4486-862B-1C2FF8382B5AQ33655590-1B8D9A88-3B4A-4903-90E4-E849BF69616DQ33685438-6CE15DFD-1E38-4A4A-AD44-1EEB2B5401D0Q33723741-2FBB3642-6D4F-4282-8621-CD19EC551A3BQ33926202-518CF89D-0640-436F-80C3-79051EB2C69EQ33989596-6556D75E-62A8-4D7A-8785-8291EA95FBEDQ33993422-EC570898-D73B-4CC3-AA28-6CCEE1C8116DQ34146222-A283271C-D6AC-426D-A4A5-EEAA96F46668Q34258204-4334195F-6D9D-441A-813F-4690905E02B1Q34288455-5BA100F1-04D1-4388-87B1-66596B2D1C31Q34326871-842F23C3-3A59-4ABC-83E4-7798BEBAAD8CQ34547920-EE9348A3-6542-4112-94D9-D7FB919976FDQ34585836-28BC94A0-367D-4B9B-BF2F-AD58F51EB756Q34622380-2C115CBC-015F-4DC4-A7E2-B2EBE1431BE5Q34626051-13429E23-2E06-4F9D-9154-666C6C562B1DQ34692741-F3C86FE7-9371-4EA0-A5E3-1D7FC213D862Q34726433-53F81E34-CF8D-4B88-9BB3-90D2214DF0CFQ34785753-20F2C2AC-59B4-45AB-8AE4-D14E218B4A22Q34803719-B48F39A7-1D1F-4739-AA6F-0122CD9BAC2BQ34803895-08FBA290-59A9-4669-A33D-B31F2478AD44Q34956351-79A610FC-3094-42C9-A4C9-3E09AE159096Q34978960-7F0E63E1-1792-4D15-8C69-7481F06E99AFQ35009362-2B3C11E3-6BB2-4D48-B32C-2C13CF798C58Q35050429-7DCB4A42-8F2A-4048-8CE2-02B395D4B2D8Q35066496-DAC84942-3C96-4411-A7F5-9D309024C717Q35204087-2313C2AD-C9E9-4E8F-B190-817F90F02EDBQ35217473-E5B18CC6-AFA0-4A18-969A-F2D8063010FEQ35236446-72DF72EA-5E94-4BFA-BCEA-12458916D0A7Q35573425-E6EE0DAA-0510-4AD8-9AAF-5DB08B6FCEA8Q35599625-62494CD8-F3D2-4960-9136-957526A315C0
P2860
Neuroplasticity and cellular resilience in mood disorders.
description
2000 nî lūn-bûn
@nan
2000 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Neuroplasticity and cellular resilience in mood disorders.
@ast
Neuroplasticity and cellular resilience in mood disorders.
@en
Neuroplasticity and cellular resilience in mood disorders.
@nl
type
label
Neuroplasticity and cellular resilience in mood disorders.
@ast
Neuroplasticity and cellular resilience in mood disorders.
@en
Neuroplasticity and cellular resilience in mood disorders.
@nl
prefLabel
Neuroplasticity and cellular resilience in mood disorders.
@ast
Neuroplasticity and cellular resilience in mood disorders.
@en
Neuroplasticity and cellular resilience in mood disorders.
@nl
P2093
P2860
P356
P1433
P1476
Neuroplasticity and cellular resilience in mood disorders.
@en
P2093
P2860
P2888
P304
P356
10.1038/SJ.MP.4000811
P407
P577
2000-11-01T00:00:00Z